Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
Kamili Bell Hill, author of "Happy Plants, Happy You: A Plant-Care & Self-Care Guide for the Modern Houseplant Parent," explains what you can do to make your houseplants thrive.
Marci Hopkins, recovery expert and author of "Chaos to Clarity: Seeing The Signs and Breaking The Cycles," talks about her own intergenerational experience with addiction that drove her to make changes and help others.
The Centers for Disease Control and Prevention announced that it will expand its infectious disease surveillance programs at major airports around the country.
Astronaut Thomas Kenneth Mattingly, who helped bring the crew of Apollo 13 back to earth after an explosion threatened their lunar mission, has died at 87.
